TITLE

INTEGRATIVE CHIROPRACTIC MANAGEMENT OF HIGH BLOOD PRESSURE AND CHRONIC HYPERTENSION: AN EXCERPT FOCUSING ON VITAMIN D AND COENZYME Q-10

AUTHOR(S)
Vasquez, Alex
PUB. DATE
March 2012
SOURCE
Original Internist;Mar2012, Vol. 19 Issue 1, p18
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the management of chronic hypertension through Vitamin D and CoQ-10 supplementations. Vitamin D3 therapy can reduce blood pressure in cholecalciferol-deficient hypertensive patients with collateral benefits such as muscle strength, cognition and balance. CoQ-10 doses typically lowers blood pressure and is safer than all antihypertensive medications. It suggests that Vitamin D and CoQ-10 supplements can correct nutritional deficiency and restore homeodynamic mechanisms.
ACCESSION #
74611900

 

Related Articles

  • Colecalciferol.  // Reactions Weekly;1/21/2017, Vol. 1635 Issue 1, p92 

    An abstract of the article "Successful desensitization to vitamin D in a patient with vitamin D deficiency" by D. Unal and others is presented.

  • Vitamin D Produces Modest Improvement in Fibromyalgia. Gaby, Alan R. // Townsend Letter;Jul2011, Issue 336, p39 

    The article discusses the study "Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial," by D. S. Arvold and colleagues, published in a 2009 issue of "Endocrine Practice," about how vitamin D supplementation produces...

  • Impact of Two Regimens of Vitamin D Supplementation on Calcium - Vitamin D - PTH Axis of Schoolgirls of Delhi. MARWAHA, RAMAN K.; TANDON, NIKHIL; AGARWAL, NEHA; PURI, SEEMA; AGARWAL, RASHMI; SINGH, SATVEER; MANI, KALAIVANI // Indian Pediatrics;Sep2010, Vol. 47 Issue 9, p761 

    Objective: To determine the efficacy of supplementation with oral vitamin D3 (cholecalciferol) on bone mineral biochemical parameters of school-going girls. Setting: Government school (government-aided) and Private school (fee paying) in Delhi. Design: Randomized controlled trial. Intervention:...

  • Serum sclerostin is decreased following vitamin D treatment in young vitamin D-deficient female adults. Cidem, Muharrem; Karacan, Ilhan; Arat, Neval; Zengi, Oguzhan; Ozkaya, Murat; Guzel, Saadet; Ozkan, Cansu; Beytemur, Ozan // Rheumatology International;Oct2015, Vol. 35 Issue 10, p1739 

    Sclerostin is produced almost exclusively by osteocytes, which also express receptors for 1,25 dihydroxyvitamin D3. The aim of this study was to investigate the effects of vitamin D3 treatment on serum sclerostin levels in young adult females with severe vitamin D deficiency. A total of 26...

  • Evaluation of ergocalciferol or cholecalciferol dosing, 1600 IU daily or 50,000 IU monthly in older adults. Luvai, Ahai // Annals of Clinical Biochemistry;Nov2011, Vol. 48 Issue 6, p586 

    The authors provide insight on the evaluation of ergocalciferol or cholecalciferol dosing in older adults. The note the study's emphasis on the effect of D2 or D3 on the circulation of 25(OH)D concentration. They point out the significance of between-individual variability. They also mention the...

  • Editorials. Pettifor, John; Jacobs, Benjamin; Saha, Abhijeet; Sethi, Sidharth // Indian Pediatrics;Apr2014, Vol. 51 Issue 4, p259 

    The authors discuss several topics related to pediatrics. Topics covered include the management of vitamin D deficiency rickets, the adequacy of a single oral dose of 300,000 IU vitamin D3 to treat nutritional rickets, and the use of cystatin C and creatinine based equation to predict glomerular...

  • Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn's disease patients. Bartels, Lars; Bendix, Mia; Hvas, Christian; Jørgensen, Søren; Agnholt, Jørgen; Agger, Ralf; Dahlerup, Jens // Inflammopharmacology;Apr2014, Vol. 22 Issue 2, p95 

    Background: Low serum vitamin D levels may provoke or aggravate Crohn's disease (CrD). Vitamin D3 is a well-known immune modulator that affects immune functions in vitro and may prevent CrD flares. Dendritic cells (DC) are key mediators of vitamin D3 effects. In this study, we describe changes...

  • The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study. Molina, Pablo; Górriz, José L.; Molina, Mariola D.; Peris, Ana; Beltrán, Sandra; Kanter, Julia; Escudero, Verónica; Romero, Ramón; Pallardó, Luis M. // Nephrology Dialysis Transplantation;Jan2014, Vol. 29 Issue 1, p97 

    Background Growing evidence indicates that vitamin D receptor activation may have antiproteinuric effects. We aimed to evaluate whether vitamin D supplementation with daily cholecalciferol could reduce albuminuria in proteinuric chronic kidney disease (CKD) patients. Methods This 6-month...

  • Effect of vitamin D supplementation on cathelicidin, IFN-γ, IL-4 and Th1/Th2 transcription factors in young healthy females. Das, M; Tomar, N; Sreenivas, V; Gupta, N; Goswami, R // European Journal of Clinical Nutrition;Mar2014, Vol. 68 Issue 3, p338 

    Objectives:We assessed the effect of cholecalciferol and calcium supplementation on mRNA expression of cathelicidin (LL-37), Th1 and Th2 cytokines and their transcription factors in the peripheral blood mononuclear cells (PBMCs) in healthy females with vitamin D deficiency...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics